LTBP-4 Antibodies

Santa Cruz Biotechnology delivers a wide array of LTBP-4 monoclonal antibodies for research applications. LTBP-4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LTBP-4, or latent transforming growth factor-beta binding protein 4, plays a crucial role in the regulation of TGF-beta signaling, which is essential for various cellular processes, including cell growth, differentiation, and extracellular matrix production. Understanding LTBP-4 function is vital for elucidating its involvement in developmental biology and disease mechanisms, particularly in fibrosis and cancer progression. LTBP-4 research has revealed significant insights into tissue development and repair mechanisms. Ongoing studies continue to uncover new roles for LTBP-4 in maintaining cellular homeostasis and regulating growth factor availability. Recent findings highlight LTBP-4's importance in embryonic development and tissue maintenance. Characterization of LTBP-4 monoclonal antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance their understanding of human health and disease mechanisms.